EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation

Marilena Christodoulou iD, Terence J Aspray, Isabelle Piec, William D Fraser, Inez Schoenmakers, VDOP Trial group

Age and Ageing · 2024

DOI: 10.1093/ageing/afae096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, 2024. Verfasst von Marilena Christodoulou und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of East Anglia, Norwich Medical School, Norwich, UK. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Renal Insufficiency, Chronic, Dietary Supplements, Glomerular Filtration Rate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arthritis Research UK, Medical Research Council, Academy of Medical Sciences Springboard.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Chronic kidney disease (CKD) leads to alterations in fibroblast growth factor 23 (FGF23) and the renal-bone axis. This may be partly driven by altered inflammation and iron status. Vitamin D supplementation may reduce inflammation. Objective and methods Older adults with early CKD (estimated glomerular filtration rate (eGFR) 30–60 ml/min/1.73 m2; CKDG3a/b; n = 35) or normal renal function (eGFR >90 ml/min/1.73 m2; CKDG1; n = 35) received 12,000, 24,000 or 48,000 IU D3/month for 1 year. Markers of the renal-bone axis, inflammation and iron status were investigated pre- and post-supplementation. Predictors of c-terminal and intact FGF23 (cFGF23; iFGF23) were identified by univariate and multivariate regression.

Results

Pre-supplementation, comparing CKDG3a/b to CKDG1, plasma cFGF23, iFGF23, PTH, sclerostin and TNFα were significantly higher and Klotho, 1,25-dihydroxyvitamin D and iron were lower. Post-supplementation, only cFGF23, 25(OH)D and IL6 differed between groups. The response to supplementation differed between eGFR groups. Only in the CKDG1 group, phosphate decreased, cFGF23, iFGF23 and procollagen type I N-propeptide increased. In the CKDG3a/b group, TNFα significantly decreased, and iron increased. Plasma 25(OH)D and IL10 increased, and carboxy-terminal collagen crosslinks decreased in both groups. In univariate models cFGF23 and iFGF23 were predicted by eGFR and regulators of calcium and phosphate metabolism at both time points; IL6 predicted cFGF23 (post-supplementation) and iFGF23 (pre-supplementation) in univariate models. Hepcidin predicted post-supplementation cFGF23 in multivariate models with eGFR.

Conclusion

Alterations in regulators of the renal-bone axis, inflammation and iron status were found in early CKD. The response to vitamin D3 supplementation differed between eGFR groups. Plasma IL6 predicted both cFGF23 and iFGF23 and hepcidin predicted cFGF23.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23Renal Insufficiency, ChronicDietary SupplementsGlomerular Filtration RateBiomarkersFibroblast Growth FactorsIronKidneyVitamin DHumansAgedMaleFemaleAged, 80 and overTreatment OutcomeInflammationInflammation MediatorsAge FactorsCholecalciferolTime FactorsBone and Bones

Stichwörter der Autor:innen

fibroblast growth factor 23inflammation markersiron statusolder peoplerenal impairmentvitamin D

Substanzen

Fibroblast Growth Factor-23BiomarkersFibroblast Growth FactorsIronVitamin DInflammation MediatorsCholecalciferolFGF23 protein, human

Autor:innen und Institutionen

  • University of East Anglia, Norwich Medical School, Norwich, UK.
  • Freeman Hospital, Bone Clinic, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
  • Clinical Biochemistry, Department of Laboratory Medicine and Department of Diabetes and Endocrinology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK.
  • MRC Human Nutrition Research, Cambridge, UK.

ORCID-Profile: Marilena Christodoulou

Förderung

  • Arthritis Research UK
  • Medical Research Council
  • Academy of Medical Sciences Springboard

Zitieren

APA

Christodoulou, M., Aspray, T. J., Piec, I., Fraser, W. D., Schoenmakers, I., & VDOP Trial group (2024). Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation. Age and Ageing. https://doi.org/10.1093/ageing/afae096

Vancouver

Christodoulou M, Aspray TJ, Piec I, Fraser WD, Schoenmakers I, VDOP Trial group. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation. Age and Ageing. 2024. doi:10.1093/ageing/afae096

BibTeX
@article{Christodoulou2024,
  author = {Christodoulou, Marilena and Aspray, Terence J and Piec, Isabelle and Fraser, William D and Schoenmakers, Inez and VDOP Trial group, VDOP Trial group},
  title = {Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation},
  journal = {Age and Ageing},
  year = {2024},
  doi = {10.1093/ageing/afae096}
}
Kostenlos starten →